Source: International Congress 2018 – Clinical markers of asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Castillo Vizuete (Barcelona, Spain), C. Picado (Barcelona, Spain), V. Plaza (Barcelona, Spain), G. Rodrigo (Montevideo, Uruguay), B. Juliá (Madrid, Spain), C. Fernandez (Madrid, Spain), J. Mullol (Barcelona , Spain). Loss of smell: a clinical marker of severe asthma. 3984

Member's Comments

No comment yet.

Related content which might interest you: Upregulation of interleukin-19 in severe asthma: a potential saliva biomarker for asthma severity Source: ERJ Open Res, 7 (3) 00984-2020; 10.1183/23120541.00984-2020 Year: 2021 Measuring inflammation inpaediatric severe asthma: biomarkers in clinical practice Source: Breathe, 16 (1) 190301; 10.1183/20734735.0301-2019 Year: 2020 Distribution of biomarkers in severe asthma and severe uncontrolled asthma Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research Year: 2021 Clinical phenotypes of severe asthma: adults Source: Eur Respir Monogr 2019; 84: 48-63 Year: 2019 Clinical phenotypes of severe asthma: children Source: Eur Respir Monogr 2019; 84: 64-81 Year: 2019 Are acute exacerbation blood eosinophil numbers associated with clinical pattern of preschool wheeze? Source: International Congress 2015 – More paediatric asthma and allergy Year: 2015 Management of difficult-to-treat severe asthma Source: Eur Respir Mon 2011; 51: 282-296 Year: 2011 Defining the clinical clusters of severe asthma within UBIOPRED Source: International Congress 2015 – Fingerprinting severe asthma Year: 2015 Chronic cough and sputum production: a clinical COPD phenotype? Source: Eur Respir J 2012; 40: 4-6 Year: 2012 Improved definition of severe asthma phenotypes Source: International Congress 2014 – PG05 Severe asthma – highlights from the ERS/ATS workshop Year: 2014 Evolution from mild to severe asthma; the severe asthma clinic perspective Source: International Congress 2019 – Clinical implications of asthma management Year: 2019 Complex lung function in severe asthma: seeing is believing Source: Eur Respir J 2016; 48: 294-296 Year: 2016 Only severe asthma? Source: International Congress 2019 – PG11 Severe paediatric asthma Year: 2019 The frequent exacerbator phenotype in asthma: a clinical characterization Source: Virtual Congress 2020 – Phenotypes of obstructive diseases Year: 2020 Difficult-to-treat asthma: how serious is the problem and what are the issues? Source: Eur Respir Mon 2011; 51: 1-15 Year: 2011 Clinical markers of disease severity in the assessment of airway inflammation in patients with persistent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 335s Year: 2001 The clinical features of asthma-COPD overlap syndrome compared to asthma with irreversible airway obstruction Source: International Congress 2015 – Co-existing diseases and asthma Year: 2015 Dynapenia in COPD exacerbation: what is its relevance in clinical prognosis? Source: International Congress 2017 – Assessing functional outcomes in respiratory physiotherapy Year: 2017 Acute exacerbation phenotypes of asthma and COPD: impact on clinical outcomes Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021 Asthma phenotypes: do cough and wheeze predict exacerbations in persistent asthma? Source: Eur Respir J, 50 (6) 1701366; 10.1183/13993003.01366-2017 Year: 2017